Project Grant R01AI199143
Award Date 6/5/26
Completion Date 5/31/31
Dollars Obligated $847K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Federal Grant Award Summary New York University School of Medicine received a $250,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 6, 2025, with a completion date of July 31, 2029. The project will develop a structural causal framework for adaptive randomized clinical trials in infectious disease research, addressing critical methodological gaps in the design and...
- Federal Project Grant Award Summary Funding Agency: National Institute of Allergy and Infectious Diseases (NIAID) Federal Grant Program: Allergy and Infectious Diseases Research (CFDA 93.855) Award Amount: $791,797 Award Date: February 4, 2026 Project Period: February 4, 2026 – January 31, 2031 Awardee: New York University School of Medicine, New York, NY New York University School of Medicine is conducting investigator-initiated biomedical research to advance understanding of how the intestinal...
- Federal Grant Award Summary Funding Agency: National Institute of Allergy and Infectious Diseases (NIAID) Program: Allergy and Infectious Diseases Research (CFDA 93.855) Award Amount: $463,375 Award Date: February 2, 2026 Project Period: February 2, 2026 – January 31, 2028 Harvard College's Office for Sponsored Programs is conducting high-throughput screening research to discover novel antimicrobial metabolites produced by human gut bacteria that contribute to colonization resistance—the...
- Federal Grant Award Summary New York University School of Medicine received a $3.21 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 25, 2025, with a completion date of June 30, 2029. The award funds research into real-time detection of Staphylococcus aureus transmission in hospital settings, with particular emphasis on methicillin-resistant S. aureus (MRSA)....
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $3.52 million to Sloan-Kettering Institute for Cancer Research under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 1, 2026, for a four-year project period concluding February 28, 2030. The project develops computational and clinical tools to prevent gut-borne bloodstream infections in immunocompromised patients through microbiome-based interventions. Deliverables...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $508,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine, with an award date of April 22, 2026, and completion date of March 31, 2031. This research grant supports investigator-initiated biomedical research aimed at understanding how innate immune cells, particularly neutrophils, make critical functional decisions...
- Federal Grant Award Summary Health Research, Inc.'s Wadsworth Center received a $2,055,164 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 18, 2025, with completion targeted for June 30, 2030. The project focuses on developing the therapeutic potential of D29-LYSB, a mycobacteriophage lysin enzyme, as a broad-spectrum treatment for Mycobacterium abscessus (MAB)...
- Federal Grant Award Summary Rochester Institute of Technology received a $1.12M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 2, 2026, with a completion date of June 30, 2029. The research project focuses on surveillance of antibiotic resistance in commensal Neisseria populations to identify resistance mechanisms that may be transferred to the pathogenic Neisseria...
- Federal Grant Award Summary Duke University received a $3,012,181 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 10, 2025, with completion targeted for August 31, 2029. The grant supports research investigating dietary fiber-microbiome interactions to elucidate mechanisms for suppressing multi-drug resistant organisms (MDROs)—specifically Clostridioides...
- Federal Grant Award Summary Rockefeller University received a $798,670 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 1, 2026 through May 31, 2031. The research focuses on developing novel antibiotics through bioinformatics-guided synthesis of natural products derived from previously inaccessible microbial sources, commonly referred to as "microbial dark...